2 Amendments of Pilar AYUSO related to 2016/2174(DEC)
Amendment 6 #
Draft opinion
Paragraph 4
Paragraph 4
4. Also notes that the Authority assessed public health risks in collaboration with the European Centre for Disease Prevention and Control by leveraging combined data sets; welcomes that the Authority also works in collaboration, on occasion, with the European Medicines Agency, (e.g. presenting a first joint report on the integrated analysis of the consumption of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from humans and food-producing animals) and with the European Chemicals Agency, (e.g. on the joint development of scientific guidance to enable identification of endocrine disruptors);
Amendment 10 #
Draft opinion
Paragraph 6
Paragraph 6
6. Believes that the Authority should continue paying special attention to public opinion, and commit itself, as much as possible, to openness and transparency; welcomes, in this respect, that in 2015, the Authority successfully tested its new methodological approach to the use of scientific evidence; also welcomes, in this context, the improvements in sharing data by opening up the data warehouse of the Authority to a growing number of stakeholders; encourages the Authority to further progress on this path;welcomes the Impact Assessment1a , an external scientific report published in June 2016, of measures by the Authority specifically aimed at increasing transparency and engagement in its risk assessment process; encourages the Authority to further progress on this path, particularly in the context of its 2017 independence review; _________________ 1a"Impact Assessment of Specific Measures Aimed at Increasing Transparency and Engagement in EFSA Risk Assessment Process", EFSA Supporting publication 2016:EN-1047.